Stay updated on Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial page.

Latest updates to the Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial page
- Check2 days agoNo Change Detected
- Check8 days agoChange DetectedThe PATHFNDR-1 study page now shows a 403 Forbidden error, and the detailed study content and documents are no longer visible on the page.SummaryDifference18%

- Check16 days agoNo Change Detected
- Check29 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a minor page version update. This typically reflects maintenance or fixes and does not indicate changes to the study details shown on the page.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page revision updated from v3.6.4 to v3.6.5, signaling a new version of the page. This update does not modify the study data or content.SummaryDifference0.0%

- Check65 days agoChange DetectedA new Revision: v3.6.4 line appears, replacing the previous v3.6.3. This signals an updated revision of the page.SummaryDifference0.0%

- Check71 days agoChange DetectedThe study record now shows termination with an early stop for business reasons and a new termination date, replacing prior active recruitment details. This reflects the current status of PATHFNDR-1 on ClinicalTrials.gov and indicates enrollment and ongoing results are no longer expected.SummaryDifference0.3%

- Check85 days agoChange DetectedThe study documents revision was updated from v3.6.2 to v3.6.3, indicating a refreshed protocol and related documents. This reflects an updated version of the study paperwork used by investigators.SummaryDifference0.0%

Stay in the know with updates to Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Paltusotine for Acromegaly: Safety & Efficacy Clinical Trial page.